Elevated numbers of CD163+ macrophages in hearts of simian immunodeficiency virus-infected monkeys correlate with cardiac pathology and fibrosis

AIDS Research and Human Retroviruses

Volumn 30, Issue 7, 2014, Pages 685-694

  Walker, Joshua A ^a   Sulciner, Megan L ^a   Nowicki, Katherine D ^a   Miller, Andrew D ^b,c   Burdo, Tricia H ^a   Williams, Kenneth C ^a  

^a BOSTON COLLEGE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD163 ANTIGEN; COLLAGEN; BROXURIDINE; CD68 ANTIGEN, HUMAN; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; VIRUS FUSION PROTEIN; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL INFILTRATION; CELL MIGRATION; CONTROLLED STUDY; HEART DISEASE; HEART MUSCLE FIBROSIS; HEART VENTRICLE; MACROPHAGE; MACROPHAGE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T CELL DEPLETION; VIRUS LOAD; ANIMAL; BLOOD; COMPLICATION; CYTOLOGY; FIBROSIS; HEART MUSCLE; IMMUNOLOGY; LYMPHOCYTE DEPLETION; MONOCYTE; MYOCARDITIS; PATHOLOGY; RETROSPECTIVE STUDY; VIROLOGY;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BROMODEOXYURIDINE; CD8-POSITIVE T-LYMPHOCYTES; FIBROSIS; HEART VENTRICLES; LYMPHOCYTE DEPLETION; MACACA MULATTA; MACROPHAGE ACTIVATION; MACROPHAGES; MONOCYTES; MYOCARDITIS; MYOCARDIUM; RECEPTORS, CELL SURFACE; RETROSPECTIVE STUDIES; RNA, VIRAL; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL FUSION PROTEINS; VIRAL LOAD;

EID: 84903774119     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2013.0268     Document Type: Article

References (50)

1. Collaboration H-C, Ray M, Logan R, et al.: The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. AIDS 2010;24:123137.
2. Coquet I, Pavie J, Palmer P, et al.: Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era. Crit Care 2010;14:R107.
3. Deeks SG: HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med 2011;62:141155.
4. Williams K, Westmoreland S, Greco J, et al.: Magnetic resonance spectroscopy reveals that activated monocytes contribute to neuronal injury in SIV neuroAIDS. J Clin Invest 2005;115:25342545.
5. Crowe SM, Westhorpe CL, Mukhamedova N, Jaworowski A, Sviridov D, and Bukrinsky M: The macrophage: The intersection between HIV infection and atherosclerosis. J Leukoc Biol 2010;87:589598.
6. Currier JS, Lundgren JD, Carr A, et al.: Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy. Circulation 2008;118:e2935.
7. Ho JE and Hsue PY: Cardiovascular manifestations of HIV infection. Heart 2009;95:11931202.
8. Annamalai L, Westmoreland SV, Domingues HG, Walsh DG, Gonzalez RG, and ONeil SP: Myocarditis in CD8- depleted SIV-infected rhesus macaques after short-term dual therapy with nucleoside and nucleotide reverse transcriptase inhibitors. PLoS One 2010;5:e14429.
9. Friis-Moller N, Reiss P, Sabin CA, et al.: Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007;356:17231735.
10. Friis-Moller N, Sabin CA, Weber R, et al.: Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003;349:19932003.
11. Brenchley JM, Price DA, Schacker TW, et al.: Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006;12:13651371.
12. Pandrea I, Cornell E, Wilson C, et al.: Coagulation biomarkers predict disease progression in SIV-infected nonhuman primates. Blood 2012;120:13571366.
13. Currie PF, Goldman JH, Caforio ALP, et al.: Cardiac autoimmunity in HIV related heart muscle disease. Heart 1998;79:599604.
14. Yanai T, Lackner AA, Sakai H, Masegi T, and Simon MA: Systemic arteriopathy in SIV-infected rhesus macaques (Macaca mulatta). J Med Primatol 2006;35:106112.
15. Liu R, Moroi M, Yamamoto M, et al.: Presence and severity of Chlamydia and pneumoniae and cytomegalovirus infection in coronary plaques are associated with acute coronary syndromes. Int Heart J 2006;47:511519.
16. Roivainen M, Viik-Kajander M, Palosuo T, et al.: Infections, inflammation, and the risk of coronary heart disease. Circulation 2000;101:252257.
17. Stein JH and Hsue PY: Inflammation, immune activation, and CVD risk in individuals with HIV infection. JAMA 2012;308:405406.
18. Shannon RP, Simon MA, Mathier MA, Geng YJ, Mankad S, and Lackner AA: Dilated cardiomyopathy associated with simian AIDS in nonhuman primates. Circulation 2000; 101:185193.
19. Crowe SM and Hoy JF: Are monocytes the canary in the coal mine for HIV-related atherosclerosis? J Infect Dis 2012;206:14911493.
20. Auffray C, Sieweke MH, and Geissmann F: Blood monocytes: Development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 2009;27:669692.
21. Martinez FO, Helming L, and Gordon S: Alternative activation of macrophages: An immunologic functional perspective. Annu Rev Immunol 2009;27:451483.
22. Prabhu SD: Cytokine-induced modulation of cardiac function. Circ Res 2004;95:11401153.
23. Monsuez JJ, Escaut L, Teicher E, Charniot JC, and Vittecoq D: Cytokines in HIV-associated cardiomyopathy. Int J Cardiol 2007;120:150157.
24. Barbaro G, Di Lorenzo G, Soldini M, et al.: Clinical course of cardiomyopathy in HIV-infected patients with or without encephalopathy related to the myocardial expression of tumor necrosis factor-a and nitric oxide synthase. AIDS 2000;14:827838.
25. Fisher SD, Bowles NE, Towbin JA, and Lipshultz SE: Mediators in HIV-associated cardiovascular disease: A focus on cytokines and genes. AIDS 2003;17:S2935.
26. Thieblemont N, Weiss L, Sadeghi HM, Estcourt C, and Haeffner-Cavaillon N: CD14lowCD16high A cytokineproducing monocyte subset which expands during human immunodeficiency virus infection. Eur J Immunol 1995; 25:34183424.
27. Barisione C, Garibaldi S, Ghigliotti G, et al.: CD14CD16 monocyte subset levels in heart failure patients. Dis Markers 2010;28:115124.
28. Kristiansen M, Graversen JH, Jacobsen C, Hoffman E , Lawk SKA, and Moestrup SK: Identification of the haemoglobin scavenger receptor. Nature 2001;409:19992002.
29. Onofre G, Kolá-cková M, Jankovi-cová K, and Krejsek J: Scavenger receptor CD163 and its biological function. Acta Med 2009;52:5761.
30. Buechler C, Ritter M, Orsó E, Langmann T, Klucken J, and Schmitz G: Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli. J Leukoc Biol 2000;67: 97103.
31. Etzerodt A and Moestrup SK: CD163 and inflammation: Biological, diagnostic, and therapeutic aspects. Antioxid Redox Signal 2013;18:23522363.
32. Davis BH and Zarev PV: Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels. Cytometry B Clin Cytom 2005;63:1622.
33. Burdo TH, Soulas C, Orzechowski K, et al.: Increased monocyte turnover from bone marrow correlates with severity of SIV encephalitis and CD163 levels in plasma. PLoS Pathog 2010;6:e1000842.
34. Burdo TH, Lentz MR, Autissier P, et al.: Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy. J Infect Dis 2011;204:154163.
35. Burdo TH, Lo J, Abbara S, et al.: Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients. J Infect Dis 2011;204:12271236.
36. Pereyra F, Lo J, Triant V, et al.: Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers. AIDS 2012;26:24092415.
37. Schmitz JE, Simon MA, Kuroda MJ, et al.: A nonhuman primate model for the selective elimination of CD8 + lymphocytes using a mouse-human chimeric monoclonal antibody. Am J Pathol 1999;154:19231932.
38. Lifson JD, Rossio JL, Piatak M Jr, et al.: Role of CD8( + ) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment. J Virol 2001;75: 1018710199.
39. Williams K, Schwartz A, Corey S, et al.: Proliferating cellular nuclear antigen expression as a marker of perivascular macrophages in simian immunodeficiency virus encephalitis. Am J Pathol 2002;161:575585.
40. Ruifrok AC and Johnston DA Quantification of histochemical staining by color deconvolution. Anal Quant Cytol Hist 2001;23:291299.
41. Brower GL, Gardner JD, Forman MF, et al.: The relationship between myocardial extracellular matrix remodeling and ventricular function. Eur J Cardiothorac Surg 2006;30:604610.
42. Kelly KM, Tarwater PM, Karper JM, et al.: Diastolic dysfunction is associated with myocardial viral load in simian immunodeficiency virus-infected macaques. AIDS 2012;26:815823.
43. Yearley JH, Pearson C, Carville A, Shannon RP, and Mansfield K: SIV-associated myocarditis: Viral and cellular correlates of inflammation severity. AIDS Res Hum Retroviruses 2006;22:529540.
44. Yearley JH, Pearson C, Carville A, Shannon RP, and Mansfield K: Phenotypic variation in myocardial macrophage populations suggests a role for macrophage activation in SIV-associated cardiac disease. AIDS Res Hum Retroviruses 2007;23:512524.
45. Moestrup SK and Moller HJ: CD163: A regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response. Ann Med 2004;36:347354.
46. Moller HJ: Soluble CD163. Scand J Clin Lab Invest 2012;72:113.
47. Epelman S, Lavine KJ, Beaudin AE, et al.: Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity 2014;40:91104.
48. Baker JV, Henry WK, Patel P, et al.: Progression of carotid intima-media thickness in a contemporary human immunodeficiency virus cohort. Clin Infect Dis 2011;53:826835.
49. Kaplan RC, Sinclair E, Landay AL, et al.: T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women. J Infect Dis 2011;203:452463.
50. Subramanian S, Tawakol A, Abbara S, et al.: Arterial inflammation in patients with HIV. JAMA 2012;308:379386.